Rmanirex Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.82 M
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.66 M
- Revenue Growth 901.62%
- Profit Growth 134.33%
- Ebitda 188.63%
- Net Worth 7637.52%
- Total Assets 149.65%
About Rmanirex Pharma
Rmanirex Pharma Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 August 2020 (Four years and six months 21 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.82 M.
The company currently has active open charges totaling ₹0.66 M.
Maniraju Ravulapalli and Konduru Sandhya serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909TG2020PTC142591
- Company No.
142591
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Aug 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Rmanirex Pharma Private Limited offer?
Rmanirex Pharma Private Limited offers a wide range of products and services, including Salon, Spa Kits & Equipments, Salon Equipment, Pharma & Bioanalytical Services, PCD Pharma Franchise, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Cosmetics, Hair & Beauty Products, Beauty Cosmetics, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Rmanirex Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maniraju Ravulapalli  | Director | 07-Aug-2020 | Current |
| Konduru Sandhya | Additional Director | 14-Jan-2021 | Current |
Financial Performance of Rmanirex Pharma.
Rmanirex Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 901.62% increase. The company also saw a substantial improvement in profitability, with a 134.33% increase in profit. The company's net worth Soared by an impressive increase of 7637.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rmanirex Pharma?
In 2022, Rmanirex Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.66 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Oct 2022 | Hdfc Bank Limited | ₹0.66 M | Open |
How Many Employees Work at Rmanirex Pharma?
Rmanirex Pharma has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rmanirex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rmanirex Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
